Low-molecular-weight-heparin in recurrent implantation failure

Fertility and Sterility

Volumn 95, Issue 7, 2011, Pages

  Seshadri, Srividya ^a   Sunkara, Sesh Kamal ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLOOD CLOTTING DISORDER; FERTILIZATION IN VITRO; GRAFT FAILURE; HUMAN; LETTER; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE;

ANTICOAGULANTS; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVE BIRTH; PREGNANCY; PREGNANCY RATE; RECURRENCE; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT FAILURE;

EID: 79956355247     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.03.025     Document Type: Letter

References (2)

1. Berker B, Takn S, Kahraman K, Takn EA, Atabekolu C, Sönmezer M. The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. Fertil Steril. Published online January 17, 2011.
2. B. Urman, B. Ata, K. Yakin, C. Alatas, S. Aksoy, and R. Mercan Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial Hum Reprod 24 2009 1640 1647